Search

Luwy K Musey

from Blue Bell, PA
Age ~68
Get Report
Also known as:
Luwy Kavuka Musey, Luwy Musey Kavuk, Luwy Fomo, Luwy Akafomo, Musey Luwy, A Luwy Y, Luwy Musey A, A Y
Phone and address:
1373 Cernan Ln, Blue Bell, PA 19422
(610) 277-2995
Related to:
Clarisse AkafomoAnthony Musey, 38Kombula AkafomoNathalie Musey, 32Kimberley Musey
Connected to:
Henry K Musey, 62William M Musey, 52Keith E Musfeldt, 79Linda G Musfeldt, 70Alex Musgrave, 41Anita M Musgrave, 39Annie Musgrave, 59Barbara D Musgraves, 86Brice J Musgrave, 37Carol R Musgrave, 62

Luwy Musey Phones & Addresses

  • 1373 Cernan Ln, Blue Bell, PA 19422 (610) 277-2995
  • 15742 Densmore Ave N, Seattle, WA 98133
  • Shoreline, WA
  • North Wales, PA
  • Montgomery, PA
  • 7506 37Th Ave NE APT 3, Seattle, WA 98115

Work

Position: Machine Operators, Assemblers, and Inspectors Occupations

Education

Degree: Graduate or professional degree

Publications

Us Patents

Pneumococcal Polysaccharides And Their Use In Immunogenic Polysaccharide-Carrier Protein Conjugates

View page
US Patent:
20220323592, Oct 13, 2022
Filed:
Jun 24, 2022
Appl. No.:
17/848456
Inventors:
- Rahway NJ, US
Chitrananda Abeygunawardana - Ambler PA, US
Luwy Kavuka Musey - Blue Bell PA, US
Michael J. Kosinski - Souderton PA, US
Yadong Adam Cui - Norristown PA, US
Assignee:
Merck Sharp & Dohme LLC - Rahway NJ
International Classification:
A61K 47/61
A61K 47/64
A61P 37/04
A61K 39/09
A61K 39/39
A61K 47/02
A61K 47/22
C08B 37/00
Abstract:
The present invention provides capsular polysaccharides from serotypes identified using NMR. The present invention further provides polysaccharide-protein conjugates in which capsular polysaccharides from one or more of these serotypes are conjugated to a carrier protein such as CRM197. Polysaccharide-protein conjugates from one or more of these serotypes may be included in multivalent pneumococcal conjugate vaccines having polysaccharides from multiple additional serotypes.

Pneumococcal Polysaccharides And Their Use In Immunogenic Polysaccharide-Carrier Protein Conjugates

View page
US Patent:
20220323593, Oct 13, 2022
Filed:
Jun 24, 2022
Appl. No.:
17/848462
Inventors:
- Rahway NJ, US
Chitrananda Abeygunawardana - Ambler PA, US
Luwy Kavuka Musey - Blue Bell PA, US
Michael J. Kosinski - Souderton PA, US
Yadong Adam Cui - Norristown PA, US
Assignee:
Merck Sharp & Dohme LLC - Rahway NJ
International Classification:
A61K 47/61
A61K 47/64
A61P 37/04
A61K 39/09
A61K 39/39
A61K 47/02
A61K 47/22
C08B 37/00
Abstract:
The present invention provides capsular polysaccharides from serotypes identified using NMR. The present invention further provides polysaccharide-protein conjugates in which capsular polysaccharides from one or more of these serotypes are conjugated to a carrier protein such as CRM197. Polysaccharide-protein conjugates from one or more of these serotypes may be included in multivalent pneumococcal conjugate vaccines having polysaccharides from multiple additional serotypes.

Compositions Comprising Streptococcus Pneumoniae Polysaccharide-Protein Conjugates And Methods Of Use Thereof

View page
US Patent:
20220296695, Sep 22, 2022
Filed:
Dec 17, 2019
Appl. No.:
17/312442
Inventors:
Chitrananda ABEYGUNAWARDANA - North Wales PA, US
Yadong Adam CUI - North Wales PA, US
Romulo FERRERO - North Wales PA, US
Jian HE - West Point PA, US
Luwy MUSEY - North Wales PA, US
Tanaz PETIGARA - North Wales PA, US
Julie M. SKINNER - West Point PA, US
- Rahway NJ, US
Assignee:
Merck Sharp & Dohme Corp. - Rahway NJ
International Classification:
A61K 39/09
A61K 47/20
A61P 31/04
A61P 37/04
Abstract:
The invention is related to multivalent immunogenic compositions comprising more than one polysaccharide protein conjugates, wherein each of the conjugates comprises a polysaccharide from an serotype conjugated to a carrier protein, wherein the serotypes of are as defined herein. In some embodiments, at least one of the polysaccharide protein conjugates is formed by a conjugation reaction comprising an aprotic solvent. In further embodiments, each of the polysaccharide protein conjugates is formed by a conjugation reaction comprising an aprotic solvent. Also provided are methods for inducing a protective immune response in a human patient comprising administering the multivalent immunogenic compositions of the invention to the patient. The multivalent immunogenic compositions are useful for providing protection against infection and/or pneumococcal diseases caused by The compositions of the invention are also useful as part of treatment regimes that provide complementary protection for patients that have been vaccinated with a multivalent vaccine indicated for the prevention of pneumococcal disease.

Pneumococcal Polysaccharides And Their Use In Immunogenic Polysaccharide-Carrier Protein Conjugates

View page
US Patent:
20230107713, Apr 6, 2023
Filed:
Sep 22, 2022
Appl. No.:
17/934396
Inventors:
- Rahway NJ, US
Chitrananda Abeygunawardana - Ambler PA, US
Luwy Kavuka Musey - Blue Bell PA, US
Michael J. Kosinski - Souderton PA, US
Yadong Adam Cui - Norristown PA, US
Julie Marie Skinner - Phoenixville PA, US
Assignee:
Merck Sharp & Dohme LLC - Rahway NJ
International Classification:
A61K 39/09
A61K 39/39
A61K 47/42
Abstract:
The present invention provides capsular polysaccharides from serotypes identified using NMR The present invention further provides polysaccharide-protein conjugates in which capsular polysaccharides from one or more of these serotypes are conjugated to a carrier protein such as CRM197. Polysaccharide-protein conjugates from one or more of these serotypes may be included in multivalent pneumococcal conjugate vaccines having polysaccharides from multiple additional serotypes.

Pneumococcal Polysaccharides And Their Use In Immunogenic Polysaccharide-Carrier Protein Conjugates

View page
US Patent:
20230094548, Mar 30, 2023
Filed:
Sep 27, 2022
Appl. No.:
17/935856
Inventors:
- Rahway NJ, US
Chitrananda Abeygunawardana - Ambler PA, US
Luwy Kavuka Musey - Blue Bell PA, US
Michael J. Kosinski - Souderton PA, US
Yadong Adam Cui - Norristown PA, US
Julie Marie Skinner - Phoenixville PA, US
Assignee:
Merck Sharp & Dohme LLC - Rahway NJ
International Classification:
A61K 39/09
A61K 39/39
A61K 47/42
Abstract:
The present invention provides capsular polysaccharides from serotypes identified using NMR. The present invention further provides polysaccharide-protein conjugates in which capsular polysaccharides from one or more of these serotypes are conjugated to a carrier protein such as CRM197. Polysaccharide-protein conjugates from one or more of these serotypes may be included in multivalent pneumococcal conjugate vaccines having polysaccharides from multiple additional serotypes.

Pneumococcal Polysaccharides And Their Use In Immunogenic Polysaccharide-Carrier Protein Conjugates

View page
US Patent:
20230075760, Mar 9, 2023
Filed:
Sep 22, 2022
Appl. No.:
17/934379
Inventors:
- Rahway NJ, US
Chitrananda Abeygunawardana - Ambler PA, US
Luwy Kavuka Musey - Blue Bell PA, US
Michael J. Kosinski - Souderton PA, US
Yadong Adam Cui - Norristown PA, US
Julie Marie Skinner - Phoenixville PA, US
Assignee:
Merck Sharp & Dohme LLC - Rahway NJ
International Classification:
A61K 39/09
A61K 39/39
A61K 47/42
Abstract:
The present invention provides capsular polysaccharides from serotypes identified using NMR. The present invention further provides polysaccharide-protein conjugates in which capsular polysaccharides from one or more of these serotypes are conjugated to a carrier protein such as CRM197. Polysaccharide-protein conjugates from one or more of these serotypes may be included in multivalent pneumococcal conjugate vaccines having polysaccharides from multiple additional serotypes.

Pneumococcal Polysaccharides And Their Use In Immunogenic Polysaccharide-Carrier Protein Conjugates

View page
US Patent:
20230041441, Feb 9, 2023
Filed:
Sep 27, 2022
Appl. No.:
17/935864
Inventors:
- Rahway NJ, US
Chitrananda Abeygunawardana - Ambler PA, US
Luwy Kavuka Musey - Blue Bell PA, US
Michael J. Kosinski - Souderton PA, US
Yadong Adam Cui - Norristown PA, US
Julie Marie Skinner - Phoenixville PA, US
Assignee:
Merck Sharp & Dohme LLC - Rahway NJ
International Classification:
A61K 39/09
A61K 39/39
A61K 47/42
Abstract:
The present invention provides capsular polysaccharides from serotypes identified using NMR. The present invention further provides polysaccharide-protein conjugates in which capsular polysaccharides from one or more of these serotypes are conjugated to a carrier protein such as CRM197. Polysaccharide-protein conjugates from one or more of these serotypes may be included in multivalent pneumococcal conjugate vaccines having polysaccharides from multiple additional serotypes.

Pneumococcal Polysaccharides And Their Use In Immunogenic Polysaccharide-Carrier Protein Conjugates

View page
US Patent:
20230029424, Jan 26, 2023
Filed:
Sep 27, 2022
Appl. No.:
17/935871
Inventors:
- Rahway NJ, US
Chitrananda Abeygunawardana - Ambler PA, US
Luwy Kavuka Musey - Blue Bell PA, US
Michael J. Kosinski - Souderton PA, US
Yadong Adam Cui - Norristown PA, US
Julie Marie Skinner - Phoenixville PA, US
Assignee:
Merck Sharp & Dohme LLC - Rahway NJ
International Classification:
A61K 39/09
A61K 39/39
A61K 47/42
Abstract:
The present invention provides capsular polysaccharides from serotypes identified using NMR. The present invention further provides polysaccharide-protein conjugates in which capsular polysaccharides from one or more of these serotypes are conjugated to a carrier protein such as CRM197. Polysaccharide-protein conjugates from one or more of these serotypes may be included in multivalent pneumococcal conjugate vaccines having polysaccharides from multiple additional serotypes.
Control profile
Luwy K Musey from Blue Bell, PA, age ~68 Get Report